Since the quantity of PSA-NCAM has been suggested as a factor involved in schizophrenia [10], it is expected that the promoter activity of ST8SIA2 gene is a genetic determinant of schizophrenia risk through controlling the amount of enzyme that regulates PSA quantity. This evidence concerns the gene NCAM1 and schizophrenia.